We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China’s FDA Verifies Data from 55 Clinical Trials in First Audits
China’s FDA Verifies Data from 55 Clinical Trials in First Audits
As part of its clinical trial data auditing initiative, the Chinese Food and Drug Administration verified data from an initial set of 55 clinical trials, focusing mainly on large, international drugmakers.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor